Ursodeoxycholic Acid Treatment Restores Gut Microbiota and Alleviates Liver Inflammation in Non-Alcoholic Steatohepatitic Mouse Model
出版年份 2021 全文链接
标题
Ursodeoxycholic Acid Treatment Restores Gut Microbiota and Alleviates Liver Inflammation in Non-Alcoholic Steatohepatitic Mouse Model
作者
关键词
-
出版物
Frontiers in Pharmacology
Volume 12, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2021-12-06
DOI
10.3389/fphar.2021.788558
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Epidemiological feature of NAFLD from 1999 to 2018 in China
- (2020) Jianghua Zhou et al. HEPATOLOGY
- Investigation of gut microbiome changes in type 1 diabetic mellitus rats based on high-throughput sequencing
- (2020) Quantao Ma et al. BIOMEDICINE & PHARMACOTHERAPY
- Nonalcoholic Steatohepatitis
- (2020) Adam C. Sheka et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- PICRUSt2 for prediction of metagenome functions
- (2020) Gavin M. Douglas et al. NATURE BIOTECHNOLOGY
- Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders
- (2020) Judith Aron-Wisnewsky et al. Nature Reviews Gastroenterology & Hepatology
- Multiple Parallel Hits Hypothesis in NAFLD – Revisited After a Decade
- (2020) Herbert Tilg et al. HEPATOLOGY
- Parabacteroides distasonis Alleviates Obesity and Metabolic Dysfunctions via Production of Succinate and Secondary Bile Acids
- (2019) Kai Wang et al. Cell Reports
- The Intestinal Microbiome, Plasma Metabolome and Liver Transcriptome- A Conspiracy Driving Hepatic Steatosis
- (2019) Wajahat Z Mehal et al. HEPATOLOGY
- Towards a standard diet-induced and biopsy-confirmed mouse model of non-alcoholic steatohepatitis: Impact of dietary fat source
- (2019) Michelle L Boland et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Ursodeoxycholic acid is a GPBAR1 agonist and resets liver/intestinal FXR signaling in a model of diet-induced dysbiosis and NASH
- (2019) Adriana Carino et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- NASH Leading Cause of Liver Transplant in Women: Updated Analysis of Indications For Liver Transplant and Ethnic and Gender Variances
- (2018) Mazen Noureddin et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- OUP accepted manuscript
- (2018) BIOINFORMATICS
- Ursodeoxycholic acid improves liver function via phenylalanine/tyrosine pathway and microbiome remodelling in patients with liver dysfunction
- (2018) Da Jung Kim et al. Scientific Reports
- Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease
- (2017) Feng Shen et al. Hepatobiliary & Pancreatic Diseases International
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
- (2017) Naga Chalasani et al. HEPATOLOGY
- New trends on obesity and NAFLD in Asia
- (2017) Jian-Gao Fan et al. JOURNAL OF HEPATOLOGY
- Ursodeoxycholic Acid Suppresses Lipogenesis in Mouse Liver: Possible Role of the Decrease in β-Muricholic Acid, a Farnesoid X Receptor Antagonist
- (2017) Kyosuke Fujita et al. LIPIDS
- Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- The role of the gut microbiota in NAFLD
- (2016) Christopher Leung et al. Nature Reviews Gastroenterology & Hepatology
- Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis
- (2015) Eduardo Vilar-Gomez et al. GASTROENTEROLOGY
- Comparison of immunoreactive score, HER2/neuscore and H score for the immunohistochemical evaluation of somatostatin receptors in bronchopulmonary neuroendocrine neoplasms
- (2015) Elisa Specht et al. HISTOPATHOLOGY
- Beneficial effects of combined ursodeoxycholic acid and angiotensin-II type 1 receptor blocker on hepatic fibrogenesis in a rat model of nonalcoholic steatohepatitis
- (2015) Tadashi Namisaki et al. JOURNAL OF GASTROENTEROLOGY
- Ursodeoxycholic acid exerts farnesoid X receptor-antagonistic effects on bile acid and lipid metabolism in morbid obesity
- (2015) Michaela Mueller et al. JOURNAL OF HEPATOLOGY
- Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
- (2015) Brent A Neuschwander-Tetri et al. LANCET
- Bile acid supplementation improves established liver steatosis in obese mice independently of glucagon-like peptide-1 secretion
- (2014) Pablo Quintero et al. JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY
- Potency of Individual Bile Acids to Regulate Bile Acid Synthesis and Transport Genes in Primary Human Hepatocyte Cultures
- (2014) Jie Liu et al. TOXICOLOGICAL SCIENCES
- UPARSE: highly accurate OTU sequences from microbial amplicon reads
- (2013) Robert C Edgar NATURE METHODS
- Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials
- (2012) G. Musso et al. DIABETOLOGIA
- FLASH: fast length adjustment of short reads to improve genome assemblies
- (2011) T. Magoc et al. BIOINFORMATICS
- Ursodeoxycholic acid dose-dependently improves liver injury in rats fed a methionine- and choline-deficient diet
- (2011) Vyacheslav U. Buko et al. HEPATOLOGY RESEARCH
- High-dose ursodeoxycholic acid therapy for nonalcoholic steatohepatitis: a double-blind, randomized, placebo-controlled trial
- (2010) Ulrich F. H. Leuschner et al. HEPATOLOGY
- A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis
- (2010) Vlad Ratziu et al. JOURNAL OF HEPATOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now